These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15372231)

  • 1. Evaluation of cysteine proteases of Plasmodium vivax as antimalarial drug targets: sequence analysis and sensitivity to cysteine protease inhibitors.
    Na BK; Kim TS; Rosenthal PJ; Lee JK; Kong Y
    Parasitol Res; 2004 Oct; 94(4):312-7. PubMed ID: 15372231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and biochemical characterization of vivapains, cysteine proteases of the malaria parasite Plasmodium vivax.
    Na BK; Shenai BR; Sijwali PS; Choe Y; Pandey KC; Singh A; Craik CS; Rosenthal PJ
    Biochem J; 2004 Mar; 378(Pt 2):529-38. PubMed ID: 14629194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A knowledge-based approach for identification of drugs against vivapain-2 protein of Plasmodium vivax through pharmacophore-based virtual screening with comparative modelling.
    Yadav MK; Singh A; Swati D
    Appl Biochem Biotechnol; 2014 Aug; 173(8):2174-88. PubMed ID: 24970047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartic proteases of Plasmodium vivax are highly conserved in wild isolates.
    Na BK; Lee EG; Lee HW; Cho SH; Bae YA; Kong Y; Lee JK; Kim TS
    Korean J Parasitol; 2004 Jun; 42(2):61-6. PubMed ID: 15181345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and structural characterization of PvSERA4: potential implication as therapeutic target for Plasmodium vivax malaria.
    Rahul CN; Shiva Krishna K; Pawar AP; Bai M; Kumar V; Phadke S; Rajesh V
    J Biomol Struct Dyn; 2014 Apr; 32(4):580-90. PubMed ID: 23582016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of vivapain-2 and vivapain-3, cysteine proteases from Plasmodium vivax: comparative protein modeling and docking studies.
    Desai PV; Avery MA
    J Biomol Struct Dyn; 2004 Jun; 21(6):781-90. PubMed ID: 15107000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
    Singh A; Rosenthal PJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):949-51. PubMed ID: 11181388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a Plasmodium vivax cysteine proteinase gene identifies uniquely conserved amino acids that may mediate the substrate specificity of malarial hemoglobinases.
    Rosenthal PJ; Ring CS; Chen X; Cohen FE
    J Mol Biol; 1994 Aug; 241(2):312-6. PubMed ID: 8057374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falcipains and other cysteine proteases of malaria parasites.
    Rosenthal PJ
    Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium.
    Hansen G; Heitmann A; Witt T; Li H; Jiang H; Shen X; Heussler VT; Rennenberg A; Hilgenfeld R
    Structure; 2011 Jul; 19(7):919-29. PubMed ID: 21742259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.
    Bouillon A; Giganti D; Benedet C; Gorgette O; Pêtres S; Crublet E; Girard-Blanc C; Witkowski B; Ménard D; Nilges M; Mercereau-Puijalon O; Stoven V; Barale JC
    J Biol Chem; 2013 Jun; 288(25):18561-73. PubMed ID: 23653352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine proteases of malaria parasites.
    Rosenthal PJ
    Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine proteases of malaria parasites: targets for chemotherapy.
    Rosenthal PJ; Sijwali PS; Singh A; Shenai BR
    Curr Pharm Des; 2002; 8(18):1659-72. PubMed ID: 12132997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-specific antimalarial activity of cysteine protease inhibitors.
    Shenai BR; Semenov AV; Rosenthal PJ
    Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial activities of novel synthetic cysteine protease inhibitors.
    Lee BJ; Singh A; Chiang P; Kemp SJ; Goldman EA; Weinhouse MI; Vlasuk GP; Rosenthal PJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3810-4. PubMed ID: 14638488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial synergy of cysteine and aspartic protease inhibitors.
    Semenov A; Olson JE; Rosenthal PJ
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2254-8. PubMed ID: 9736544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2'.
    Singh N; Sijwali PS; Pandey KC; Rosenthal PJ
    Exp Parasitol; 2006 Mar; 112(3):187-92. PubMed ID: 16337629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.
    Rosenthal PJ; Lee GK; Smith RE
    J Clin Invest; 1993 Mar; 91(3):1052-6. PubMed ID: 8450035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.
    Teixeira C; Gomes JR; Gomes P
    Curr Med Chem; 2011; 18(10):1555-72. PubMed ID: 21428877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium falciparum metacaspase PfMCA-1 triggers a z-VAD-fmk inhibitable protease to promote cell death.
    Meslin B; Beavogui AH; Fasel N; Picot S
    PLoS One; 2011; 6(8):e23867. PubMed ID: 21858231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.